Boston CEO
November 2-3, 2026
Mandarin Oriental Hotel, Boston
Co-hosted with leaders in the industry, join Longwood Healthcare Leaders this fall as top BioPharma executives convene for off-the-record discussions and top tier networking with BioPharma CEOs, heads of research and development, life science investors, and leading academics.
Highlights
Boston CEO is co-hosted with leaders in the industry. See testimonials and highlights from speakers and attendees including MA Governor Maura Healey, Boston Mayor Michelle Wu, George Yancopoulos (CSO, Regeneron), Fiona Marshall (President, NIBR), Sally Kornbluth (President, MIT), Robert Plenge (Chief Research Officer, BMS), among others.
Longwood Healthcare Leaders Boston CEO 2025
Longwood Healthcare Leaders Boston CEO 2025
Longwood Healthcare Leaders Boston CEO 2024
Boston CEO Co-Hosts
Boston CEO is co-hosted alongside leaders in the industry.
Featured Speakers
BioPharma CEOs
Research & Innovation Pioneers
R&D Leaders
Health System & Advocacy Leaders
Pharma BD & Research Leaders
Blue-Chip Investors
Venue
Longwood Healthcare Leaders Boston CEO
is held at the Mandarin Oriental, Boston
2nd Floor Ballroom
776 Boylston St, Boston, MA 02199
617-535 8888
Agenda
Monday, November 2, 2026
7:00 am | Networking Breakfast
7:40 am | Biotech Market Update & Longwood Fund Introduction
Christoph Westphal, General Partner, Longwood Fund
8:00 am | Translating Science into Medicine
Laurent Levy, CEO, Nanobiotix
Michelle Longmire, CEO, Medable
Kia Motesharei, President & COO ReAlta Life Sciences
Brendan Smith, CEO, Weaver Biosciences
Moderator: Kyle Lefkoff, General Partner, Boulder Ventures
8:30 am | Ecosystem of External Innovation
Nadim Ahmed, CEO, Cullinan Therapeutics
Jeanne Cunicelli, President, UPMC Enterprises
Anne Klibanski, CEO, Mass General Brigham
Scott Requadt, CEO, Prolium Bioscience
Moderator: Ferran Prat, CCO, BostonGene
9:00 am | Developing a Robust Pipeline
Giulio Draetta, Chief Strategy Officer, Orionis
Jason Luke, CMO, Strand Therapeutics
Helen Sabzevari, CEO, Precigen
Cynthia Verst, President, Design & Delivery Innovation, IQVIA
Moderator: Gilmore O’Neill, CEO, Editas Medicine
9:30 am | Fireside Chat
Phil Sharp, Nobel laureate; Co-Founder, Alnylam/Biogen
Moderator: Christoph Westphal, Founder/CEO/Lead Investor, Alnylam
9:50 am | Networking Break
10:20 am | R&D Collaboration
Julie Gerberding, CEO, Foundation for the NIH; former Director, CDC
Benjamin Moutier, SVP, Infectious Disease, AstraZeneca
Shinji Okitsu, Head, Research Strategic Collaborations & Partnerships, Sanofi
Stef van Grieken, CEO, Cradle
Moderator: Brad Margus, Chair, Cerevance; Chair, A-T Children’s Project
10:50 am | Delivering the Next Generation of Diagnostics
Julian Adams, CEO, Stand Up To Cancer
Bharat Tewarie, CEO, Helio Genomics
Rehan Verjee, CEO, Precede Bio
11:20 am | Competing in a New Global Playing Field
Judy Chou, CEO, AltruBio
Ruxandra Draghia-Akli, Chair, Scientific Advisory Board, INTREPID Alliance
Kenneth Moch, CEO, Regerna Therapeutics
Ming Wang, CEO, Phanes Therapeutics
Moderator: Raj Prasad, CFO, Crispr Therapeutics
11:50 am | Gubernatorial Keynote
12:10 pm | Networking Luncheon
1:00 pm | Fireside Chat
Bob Langer, Koch Institute Professor, MIT; Co-Founder, Moderna
1:20 pm | Leveraging an Effective Board
Tim Noyes, CEO, Newleos
Rob Perez, Chair, Life Science Cares
Mike Rosenblatt, Senior Advisor, Flagship Pioneering; former CMO, Merck
Rogerio Vivaldi, Chair, Vesper Biotechnologies
Moderator: Bill Heiden, Chair, Macrogenics
1:50 pm | Biopharma Pipeline Sourcing
Bruno Gomes, Global Head, Oncology Research & Early Development, Roche
Erin Kimbrel, Head, Cell & Gene Therapy Research, Astellas
Oliver Vince, COO, Basecamp Research
Moderator: Sekhar Naik, CEO, MResult
2:20 pm | Driving Productivity in R&D
Manuel Aivado, CEO, Stelexis
Rachel Humphrey, CEO, Normunity
Samir Khleif, CEO, Georgiamune
Sarah Sheikh, Head, Global Development & SVP, Neuroscience, Takeda
Moderator: Yiannis Kiachopoulos, CEO, Causaly
2:50 pm | Networking Break
3:10 pm | Bolstering the Regulatory Strategy
Andrew Baum, Senior Strategic Advisor, Pfizer
John Butler, CEO, Akebia Therapeutics
Moderator: Chandra Ramanathan, EVP, Commercialization & Strategy, BRC Therapeutics
3:40 pm | Capital Formation and Strategic Partnerships
Reza Afkhami, CBO, Kamau Therapeutics
Jeff Aronin, CEO, Paragon Biosciences
Sean McCarthy, CEO, CytomX
Moderator: Tim Ehrlich, Partner, Gunderson Dettmer
4:10 pm | Expanding upon the Potential of Scientific Innovation
Eran Harary, CMO, Remepy
Craig Martin, CEO, Orphan Therapeutics Accelerator
Sharon Benzeno, CCO, Adaptive Biotechnologies
Skip Virgin, Head, AI Enabled Cures Frontiers, Gates Foundation
4:40 pm | Investor Outlook
Lovisa Afzelius, General Partner, Flagship Pioneering
Peter Bisgaard, Managing Director, Pivotal Life Sciences
Rakhshita Dhar, Head, Healthcare Investments, Leaps by Bayer
Raymond Kelleher, Managing Director, Cormorant
Moderator: Vikas Goyal, Partner, Longwood Fund
Tuesday, November 3, 2026
7:00 am | Networking Breakfast
7:40 am | Biotech Market Update & Longwood Fund Introduction
Christoph Westphal, General Partner, Longwood Fund
8:00 am | Building Global BioPharmas
Matt Klein, CEO, PTC Therapeutics
Pedro Lichtinger, CEO, Starton Therapeutics
Smita Pillai, SVP, Head, Innovation Center, Regeneron
David Roblin, CEO, Relation
Moderator: Richard Paulson, CEO, Karyopharm
8:30 am | Drug Approvals: Insights, Outlook, and Commitment to Patients
Annette Bakker, CEO, Children's Tumor Foundation
Jean-Frédéric Paulsen, CEO, Ferring Pharmaceuticals
Raviv Pryluk, CEO, PhaseV
Christine Roth, Head, Global Product Strategy and Commercialization, Bayer Pharmaceuticals
Moderator: Tamar Thompson, Head, Global Patient Experience, Alexion
9:00 am | Crossroads of Science and Policy: Sustaining the Engine of Innovation
Jake Auchincloss, Congressman, Massachusetts
Susan Hockfield, President Emerita, MIT
John O’Brien, CEO, National Pharmaceutical Council
Tarek Rabah, CEO, Otsuka North America
9:30 am | Fireside Chat
Jane Grogan, Head, Research, Biogen
Jeff Legos, Chief Oncology Officer, Pfizer
Robert Plenge, Chief Research Officer, BMS
9:50 am | Networking Break
10:20 am | Prioritizing the Pipeline
Christina Coughlin, CEO, Avacta Therapeutics
Marion Dorsch, CSO, Atavistik Bio
Andrew Hirsch, CEO, C4 Therapeutics
Richard Wilson, SVP, Primary Focus Lead, Genetic Regulation, Astellas
10:50 am | Advancing Late-Stage Assets
Stewart Campbell, CEO, Novita Pharmaceuticals
Abe Ceesay, CEO, Rapport Therapeutics
Anna Kazanchyan, CEO, Saghmos Therapeutics
Neil Warma, CEO, ProMIS Neurosciences
Moderator: Robert Stanislaro, Senior Managing Director, FTI Consulting
11:20 am | Managing the Runway
Chris Loose, CEO, Progentos
Bart van Rhijn, CFO, Nanobiotix
Joanna Stanicka, CEO, Axonis
Brent Vaughan, CEO, Eratos Therapeutics
Moderator: Rick Lundberg, CEO, Eikonizo
11:50 am | Fireside Chat
Mathai Mammen, CEO, Parabilis
Bill Meury, CEO, Incyte
Stefan Oelrich, CEO, Bayer Pharmaceuticals
12:15 pm | Networking Luncheon
1:00 pm | Fireside Chat: Pharma R&D
Fiona Marshall, President, BioMedical Research, Novartis
David Weinreich, Global Head, R&D, EMD Serono
Moderator: Sekhar Naik, CEO, MResult
1:25 pm | Targeted Licensing & Acquisitions
Matt Hefner, Global Head, BD, Kyowa Kirin
Jeff Landau, CEO, Stipple Bio
Rick Russell, CEO, Tract Bio
Moderator: Zhen Su, CEO, Marengo Therapeutics
1:55 pm | Accelerating Drug Discovery
Aris Baras, SVP, Co-Head, Regeneron Genetic Medicines
Jacob Hooker, CEO, Sensorium Therapeutics
Szabi Nagy, CEO, Turbine
Phil Vickers, CEO, Solu Therapeutics
Moderator: Kara Carter, CEO, Viraccio Therapeutics
2:25 pm | Fireside Chat
2:45 pm | Positioning for Commercial Success
Nathan Hubbard, CEO, Flatiron Health
Kabir Nath, CEO, COMPASS Pathways
Karin Shanahan, EVP, Chief Supply Chain & Operations Officer, BMS
Dennis Velasquez, CCO, Biorce
Moderator: Vikram Karnani, CEO, Collegium Pharmaceutical
3:15 pm | Networking Break
3:40 pm | Fireside Chat
Patrizia Cavazzoni, CMO, Pfizer; former Director, CDER, FDA
4:00 pm | The Evolving Deal-Making Landscape
Al Beardsley, CEO, Cirius Therapeutics
Murray McCutcheon, SVP, Partnering, AbCellera
Hannah England, Partner, Ropes & Gray
Issei Tsukamoto, SVP, Head, BD, Astellas
Moderator: Philippe Lopes-Fernandes, CBO, Ipsen
4:30 pm | Evaluating Investment Risk
Ari Brettman, Senior Managing Director, Blackstone Life Science
Ansbert Gadicke, Managing Partner, MPM BioImpact
Pini Orbach, Managing Partner & Head, Pharma, Arkin Capital
Jason Rhodes, Partner, Atlas Venture
Moderator: Aleks Radovic-Moreno, Partner, Longwood Fund
5:00 pm | Cocktail Reception
Speaking Faculty
